Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer. (Ckvsmalm)
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer: a Prospective Multicenter Cohort Study
Sponsor: Beijing 302 Hospital
This NA trial investigates Colorectal Cancer and Liver Metastases and is currently ongoing. Beijing 302 Hospital leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Aug 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing 302 Hospital
- Beijing Ditan Hospital
- Guangxi Ruikang Hospital
- Hunan Aerospace Hospital
- Peking University Third Hospital
- Tengzhou Central People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .